Atabak Mokari, Chief Financial Officer, on July 15, 2026, sold 40,000 shares in Corcept Therapeutics (CORT) for $3,508,277. Following the Form 4 filing with the SEC, Mokari has control over a total of 16,130 common shares of the company, with 16,130 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1088856/000119312526308058/xslF345X05/ownership.xml
Brian Daniel Webster, Director, President, and Chief Executive Officer, on July 15, 2026, sold 15,000 shares in Kestra Medical Technologies (KMTS) for $336,609. Following the Form 4 filing with the SEC, Webster has control over a total of 556,937 common shares of the company, with 556,937 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1877184/000119312526308041/xslF345X05/ownership.xml
Maurice Sciammas, Executive Vice President, Worldwide Sales & Marketing, on July 15, 2026, sold 15,000 shares in Monolithic Power Systems (MPWR) for $20,245,937. Following the Form 4 filing with the SEC, Sciammas has control over a total of 234,472 common shares of the company, with 151,644 shares held directly and 82,828 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1280452/000121465926008703/xslF345X05/marketforms-73614.xml
Laura Alber, Director, President & CEO, on July 15, 2026, sold 35,000 shares in Williams Sonoma (WSM) for $7,747,893. Following the Form 4 filing with the SEC, Alber has control over a total of 922,401 common shares of the company, with 888,524 shares held directly and 33,877 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/719955/000071995526000184/xslF345X05/form4.xml